William F. Bennett, MD Board Certified Orthopedic Surgeon Designated one of the Top Orthopedic Surgeons in Sarasota by U.S. News and World Reports, Dr. Bennett has been practicing since 1995. He was ranked a Top Doctor for Orthopedic Surgery for 2013 by Sarasota Magazine and Castle Connolly Medical.
Yes, adult stem cells, not embryonic, nor fetal are found throughout our body ranging from our own blood to fat, to bone marrow, just to name a few. These cells have the ability to differentiate into bone, cartilage, tendons and ligaments and aid in the regeneration of injured tissue and accelerate healing. Dr. Bennett uses adult bone marrow derived stem cells typically procurred from the back of the pelvis bone.
There are three (3) sources of stem cells being used in orthopedics; cells from fat, cells from blood, and cells from bone marrow.
Why do we prefer bone marrow? Bone marrows progenitor/stem cells are better suited for regenerating cartilage, ligament and tendon and can be used as a direct application (in-office-injection) or as an adjunct in surgery to aid in regeneration and healing of injured tissue. This technique is point-of-care, the cells are not manipulated and are utilized as treatment at the same time of the harvest. The harvest is from the posterior (back) portion of the pelvic bone; a very short anesthesia is required. Patients rarely complain of any discomfort following the harvest, and the marrow taken grows back!
Evidence Based Applications! There continues to be expanding indications for the use of bone marrow derived adult stem cells. We are using them for cartilage damage, arthritis, rotator cuff tears, tendon tears and hip labral injuries.
Why do we not use stem cells from fat? The harvesting of cells from fat has carried over into orthopedic applications from plastic surgery applications. While they are a great source for plastic surgery and there are large numbers of them found in fat, cells, whilst lower in number, from the bone marrow are better suited for orthopedic applications.
Improvement from stem cell Injections? Early decrease in pain may be seen as quickly as 2 weeks, but the whole event may not be optimized for 3-4 months.
How long would you estimate this treatment would be effective?
This is an evolving field; and as such, it is still considered investigational from an insurance standpoint. However, the cells will help to regenerate new tissue in the proper environment and the science suggests that the tissue may be as robust as nor mal tissue. People who have had shoulder surgery and cartilage surgery with stem cells applied recovered quicker than those with the same surgery without stem cells.
What are the advantages of doing Stem Cell Therapy as opposed to a surgical procedure?
Firstly, as opposed to surgery, the risks associated with the procedure are minimal with the greatest risk being the possibility that it doesnt work. The bone marrow is replenished, rarely do hematomas form from the aspiration site and because only one aspiration from the pelvis is performed, the risk of any bone fracture is negligible. The advantages are similar in the sense that tissue regeneration may be achieved without surgery.
Steps:
Bone marrow is aspirated. The aspirate is filtered to remove bone fragments. Using a special centrifuge with aspirate container, the cells are separated from the other main components The concentrated cells are suspended in plasma and injected with PRP.
What is Stem Cell Therapy?
Bennett Orthopedics utilizes only bone marrow aspirate concentrate with no manipulation of cells as an adjunct to treating arthritis, cartilage, tendons and rotator cuff injuries.
Below is a list of just a few articles in Medical Journals discussing the research on the benefits of using Stem Cell Therapy in orthopedic applications.
Osteochondral Lesions of the Knee: A new one step repair technique with Bone Marrow-Derived Cells. Robert Budaa, Journal Bone and Joint Surgery, 2011
-Application of Bone Marrow-Derived Mesenchymal Stem Cell in a Rotator Cuff Repair Model Lawrence V Gullotta, MD, The American ]ournal of Sports Medicine, 2009
Concentration of Bone Marrow Total Nucleated Cells by a Point-of-Care Device Provides a High Yield and Preserves Their Functional Activity Patrick C. Herman Cell Transplantation Vol.16 2008
Dr. Bennett is an esteemed, experienced Sarasota orthopedic surgeon, internationally known as an expert shoulder and knee specialist. Designated one of the Top Orthopedic Surgeons in Sarasota by U.S. News and World Reports, Dr. Bennett has been practicing since 1995. As a sportsmedicine physician, he treats all injuries, but has been a pioneer in the areas of shoulder surgery, adult stem cells, and platelet rich plasma (PRP) treatment of joints. He sees patients from various parts of the world who seek his advanced expertise in treating hip, knee, elbow, and shoulder injuries. Arthroscopic rotator cuff surgery, minimally invasive custom knee replacement, cartilage regeneration, meniscus surgery, ACL reconstruction and hip arthroscopy are common procedures performed by Dr. Bennett. You will find you have come to the right place at Bennett Orthopedics and Sportsmedicine. Regenerating the Youth in You! Call at 941-404-2703 or submit our online form.
Additional Resources and Information about Stem Cells
What is Stem Cell Therapy?
Stem Cell Treatment Prices
Adult bone marrow derived Stem Cell treatment prices- $7800- in office
Adult Autologous Hematopoietic Stem Cells/PRP- $3,000
*Adult Autologous Bone Marrow Derived Stem Cells-$7,800
*Adult Autologous Bone Marrow Derived Stem Cells- bilateral-$14,000
Stem Cells: Cost, Controversy, and Clarification
Much of the controversy surrounding stem cell treatment is the result of common misunderstandings about the source of the stem cells used. The stem cells used by Dr. Bennett to treat hip, knee, and shoulder injuries come directly from the adult patients own body. No embryonic or fetal stem cells are ever used by Dr. Bennett! Your own body is a rich source of stem cells. They are present in every tissue: bone marrow, blood, fat, heart, tendonseven brain tissue. This fact is especially important, because certain types of stem cells (synovial cell derived, bone marrow, etc,) are better suited for certain types of injuries. Bone marrow and synovial stem cells are ideal for treating orthopedic injuries, while fat stem cells are more appropriate for plastic surgery.
To a lesser extent, there is also some lingering controversy about the newness and lack of long term studies of stem cells. However, Dr. Bennett, as a pioneer in the orthopedic use of stem cells, has been performing these procedures for years, which has allowed him to track his patients results and further refine his methods. As evidence of the effectiveness of stem cell treatments continues to grow, some have suggested that joint replacement surgeries will eventually be thought of as barbaric compared to less invasive injections of ones own cells.
This is a simple injection of stem cells into the knee. Research has shown that stem cells delay cartilage deterioration.
Another controversial aspect of stem cell treatment is the concern that storing stem cells damages DNA. This is not relevant to the treatment provided by expert orthopedic surgeon Dr. William Bennett, who uses the stem cells immediately after they are extracted from your bone marrow. Your stem cells are never sent to a lab or grown offsite. They are ready and used immediately to heal your injury.
Stem cells from the bone marrow are best for orthopedic bone, cartilage, tendon, ligament repair.
Some doctors are calling platelet rich plasma (PRP) stem cells, and offering the cheaper prices normally associated with PRP. While the blood and some types of PRP do have some stem cell content, these hematologic (blood-derived) stem cells are not the best-suited for regenerating tendons, bone, cartilage, or ligaments. Other doctors may offer fat cells, which are also less than ideal for specific orthopedic uses. Dr. Bennett, the Sarasota orthopedic surgeon who was one of the first in his field to include stem cells as a major part of his practice, only uses bone marrow derived stem cells to repair shoulders, knees, and hips. So while Dr. Bennetts price may not be the cheapest, he offers the best value, since you are getting the most appropriate cells most likely result in the best outcomes.
This patron polo player won the US Open Polo championship following adult stem cell treatment for a hip condition.
You might be wondering why, since stem cells are made by your own body, Dr. Bennett charges $7,800 for stem cell treatment. Dr. Bennetts $7,800 price includes extraction of cells from your bone marrow, and also one additional PRP injection, in order to optimize your results. Other doctors may quote cheap prices, but it is important to discern how many injections are in included and any facility or other add-on fees. Dr. Bennett prefers to provide his patients with a reliable, accurate price for the entire treatment, not just pieces of it. th stem-cells-knee-cartilage-injury-jpgThis patient was treated with stem cells following a patellar tendon disruption, one year earlier.
Dr. Bennett uses stem cells alone, instead of surgery, and he sometimes uses them in combination with surgery. As an expert shoulder specialist and knee specialist, he uses his years of stem cell experience to make the best recommendation for your unique case.
Continue reading here:
Stem Cells Sarasota, Tampa, Venice, Bradenton - Dr. Bennett
- Overcoming Tendonitis: How Stem Cell Treatments Are Revolutionizing Athlete Rehabilitation - Medical Tourism Magazine - February 21st, 2024
- Unproven Stem Cell Treatments Offer Hope & Risks - Healthline - January 4th, 2023
- Stem Cell or Bone Marrow Transplant Side Effects - American Cancer Society - November 24th, 2022
- Stem cell: $137 million buys more clinical trials, shared labs ... - November 24th, 2022
- Stem Cells Australia | Australian research, stem cell treatments and ... - October 29th, 2022
- What is a Bone Marrow Transplant (Stem Cell Transplant)? - Cancer.Net - October 29th, 2022
- Cameron Mathison Is Undergoing Stem Cell Treatments - October 4th, 2022
- Hiltzik: A judge undermines the FDA on stem cells - Los Angeles Times - October 4th, 2022
- Mesoblast Submits New Information to FDA IND File in Response to Items in the CRL to the Remestemcel-L BLA for SR-aGVHD - GlobeNewswire - October 4th, 2022
- 15 Years of Heart - Newswise - October 4th, 2022
- QC Kinetix (The Heights) Helping Patients Heal Better from Joint Pain Through Houston Heights Sports Medicine - Yahoo Finance - October 4th, 2022
- Sources - Minnesota Timberwolves' Karl-Anthony Towns was on bed rest for days due to throat infection - ESPN - October 4th, 2022
- Innovative spaces and an expert team help Childrens Hospital New Orleans set the standard in cancer care - NOLA.com - September 25th, 2022
- Stem Cell Transplantation: What it Is, Process & Procedure - September 16th, 2022
- New stem cell therapy provides long-term brain protection against ALS - Study Finds - September 8th, 2022
- $150 Million Gift Takes Stem Cell Research to New Heights - University of California San Diego - September 8th, 2022
- Seattle biotech company is the first to receive approval to test B cell gene therapy in humans - GeekWire - September 8th, 2022
- Kite's CAR T-cell Therapy Tecartus Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia... - September 8th, 2022
- Could Stem-Cell Based Therapy Treat Type-1 Diabetes? A New Study Demonstrates the Treatments Potential - SciTechDaily - August 30th, 2022
- Orchard Therapeutics Announces Multiple Presentations at 2022 SSIEM Annual Symposium Highlighting Neurometabolic Disease Portfolio - GlobeNewswire - August 30th, 2022
- Global Cancer Stem Cells Market Estimated to Reach $1,722.7 Million by 2026 and Grow at 10.3% CAGR in the 2019 to 2026 Timeframe | [180-Pages] Report... - August 22nd, 2022
- Getting a Stem Cell or Bone Marrow Transplant - American Cancer Society - August 14th, 2022
- Stem cell therapy to be used in treatment of long COVID by Panacell Biotech - Labiotech.eu - August 14th, 2022
- Selma Blair 'Stopped Looking in the Mirror' After MS Treatments - TooFab - August 14th, 2022
- ElevateBio Announces the Formation of a New Company With George Daley, M.D., Ph.D., and Boston Childrens Hospital to Develop iPSC-Derived Allogeneic... - August 5th, 2022
- Stem Cells Are Needed To Treat Life-Threatening Diseases - Longevity LIVE - Longevity LIVE - July 19th, 2022
- Stem Cell Hair Transplant: What Is It and When Will It Be Available? - July 11th, 2022
- Stem cell treatments and regulation - a quick guide for consumers - July 11th, 2022
- Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace - Business Wire - July 3rd, 2022
- NorthX Biologics expands to Cell Therapy: Partnership with Alder Therapeutics and new manufacturing site on Karolinska campus - GlobeNewswire - June 22nd, 2022
- Japan's five hottest biotech companies in healthcare - Labiotech.eu - June 22nd, 2022
- Sickle cell beta thalassemia: Causes, symptoms, and treatments - Medical News Today - June 22nd, 2022
- Umoja Biopharma Presents Data on its Engineered Induced Pluripotent Stem Cell Platform at the 2022 International Society for Stem Cell Research Annual... - June 22nd, 2022
- Six Things to Know About Stem Cell Treatment - HealthTechZone - May 15th, 2022
- CU Anschutz center for cell-based therapy gets $200 million expansion - The Denver Post - May 15th, 2022
- Differentiation therapy, Hox genes and Abemaciclib Research update 13th May - Brain Tumour Research - May 15th, 2022
- Here's the No. 1 Reason to Buy Vertex Pharmaceuticals Now - The Motley Fool - May 15th, 2022
- To help cope with the world's oldest population, Japan is investing in transplanted iPS stem cells - CBS News - April 19th, 2022
- Stem cell cure for lower back pain is all in the 'hiPS' - Study Finds - April 19th, 2022
- Versant-backed startup launches with plans to broaden cell therapy's reach - BioPharma Dive - April 19th, 2022
- CAR NK-Cell Therapy Is Quickly Growing in Immunotherapy - Targeted Oncology - April 19th, 2022
- Robert Vonderheide Appointed to Second Five-Year Term as Director of the Abramson Cancer Center - U Penn - April 19th, 2022
- Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer - DocWire News - April 19th, 2022
- Is Stem Cell Therapy Right for You? - Health Essentials from Cleveland Clinic - April 6th, 2022
- Cleveland Cord Blood Center and Deverra Therapeutics Announce Agreement - PR Newswire - April 6th, 2022
- Early Treatment Matters More Than Ever in Multiple Myeloma, Kumar Says - AJMC.com Managed Markets Network - April 6th, 2022
- Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives - DocWire News - March 25th, 2022
- A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma - Cureus - March 25th, 2022
- Current Strategies and the Potential of CAR T-Cell Therapy in Relapsed and Refractory MCL - AJMC.com Managed Markets Network - March 25th, 2022
- 'I wouldn't be here': Virginia girl, celebrating 11 years in remission, credits St. Jude with saving her life - News 3 WTKR Norfolk - March 25th, 2022
- This weird mouse with a tuft of human hair could be the future of a stem cell treatment for baldness - Boing Boing - January 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 20th, 2022
- How Stem Cell and Bone Marrow Transplants Are Used to ... - January 5th, 2022
- The Stem Cell Transplant Process - UChicago Medicine - January 5th, 2022
- Next Chapters: How Northern California blood recipients are doing years after donors helped save their lives - KCRA Sacramento - January 5th, 2022
- Exclusive: Ronnie Coleman on Recent Weight Gain, Current Strength, and Health Progress - BarBend - January 5th, 2022
- Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent ... - KULR-TV - November 8th, 2021
- Managing superficial pyoderma with light therapy - DVM 360 - October 28th, 2021
- New Treatments and Tips for Dealing With Blood Cancer - Curetoday.com - October 28th, 2021
- Orchard Therapeutics Outlines Comprehensive Presence at the - GlobeNewswire - October 16th, 2021
- Taking aim at the brain, Takeda strikes up cell therapy R&D alliance with Immusoft - MedCity News - October 16th, 2021
- The Impact Of Market Restrictions On The US Stem Cell Biomaterials Market - Med Device Online - October 16th, 2021
- FTC Follows Through On Prioritizing Investigations Into False Advertising In Healthcare Markets - Media, Telecoms, IT, Entertainment - United States -... - October 16th, 2021
- FDA Warns About Stem Cell Therapies | FDA - October 5th, 2021
- Anja Health Disrupts Cord Blood Banking with Heartfelt Founding Story and Ground-Breaking Mission - Digital Journal - October 5th, 2021
- Kite's Tecartus is First CAR T Therapy Approved for Adults with B-Cell ALL - Clinical OMICs News - October 5th, 2021
- Prolymphocytic Leukemia: What Is It and How Is It Treated? - Healthline - August 31st, 2021
- Researchers Gaze into Space to Envision Future of Regenerative Medicine - UPMC & Pitt Health Sciences News Blog - UPMC - August 18th, 2021
- Acute Myeloid Leukemia Treatment: What You Need to Know - Healthline - August 18th, 2021
- Study Calls for COVID-19 Vaccination in Patients With Cancer to Enable Optimal Treatment Delivery During Pandemic - OncLive - August 18th, 2021
- A Third Dose of the COVID-19 Vaccine Recommended for Some Cancer Patients With Weakened Immune Systems - On Cancer - Memorial Sloan Kettering - August 18th, 2021
- Stem cells: What they are and what they do - Mayo Clinic - June 6th, 2021
- Stem Cell Therapy for Knee Pain: What Patients Should Know - June 6th, 2021
- Study clarifies the impact of getting old on hematopoietic stem cells - Microbioz India - December 26th, 2020
- Stem Cell Therapy Shows 2-year Benefit for Progressive MS Patients in Phase 1 Trial - Multiple Sclerosis News Today - December 22nd, 2020
- New Combination Therapy Tested By Children's May Offer Hope For Leukemia Patients - WVXU - December 22nd, 2020
- Physio Logic Brings Cutting-edge Regenerative Treatments for Sport Injuries and Arthritis to New York City - PRNewswire - December 22nd, 2020
- For Patients With HMA-Resistant MDS, What Are Their Options? - AJMC.com Managed Markets Network - December 22nd, 2020
- In COVID-19 Clinical Trials, Experts from Baptist Health's Cancer Institutes Treat Patients With Mild or Severe Symptoms - Baptist Health South... - December 22nd, 2020
- SPONSORED: 12 Charities of Christmas - Anthony Nolan - The Courier - December 22nd, 2020